Advanced Technologies for Disease Intervention

Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025). Dr. Jagmohan Singh holds a Ph.D. in Biotechnology and Cancer Genomics from Punjab University, Chandigarh, India. He is currently serving as an adjunct faculty in Anatomy and Physiology at Thomas Jefferson University in Philadelphia, Pennsylvania. He has made significant contribution in Gastric Physiology and Pharmacology. His current research focus is on cancer immunotherapy and vaccine development against cancer recurrence. Dr. Singh's teaching and research experience has provided him with valuable insights into reviewing and editing scientific papers, review articles and book chapters, with diverse scientific aims. His research findings have been published in numerous internationally reputed journals. He has also made substantial contributions to cancer immunotherapy, including vaccine production, quality control, and clinical trials. As a multifaceted professional with a robust background in research, education, and administration, Dr. Singh’s contributions will be highly insightful to fulfilling the purpose of this book. Dr. Buttar has made valuable contributions to nanobiotechnology, phytomedicines, functional foods, clinical nutrition and prevention of cardiovascular diseases, obesity, and diabetes. In January 2014, the International Academy of Cardiovascular Sciences (India Section) established the "Dr. Harpal S. Buttar Oration Award" to recognize his leadership and contributions in promoting dietary and lifestyle changes in the prevention of cardiovascular diseases in Canada and around the world. Based on his scientific accomplishments and distinguished contributions he was awarded Fellowships from the Punjab Academy of Sciences, International College of Nutrition, International Academy of Cardiovascular Sciences, and Indian Society of Pharmaceutical Education and Research. In 2019 the Society for Ethnopharmacology, India, gave the Special Recognition Award to Dr. Buttar for his outstanding contributions made in Phytomedicines and promotion of research in Pharmacology and Pharmaceutical Sciences.He has authored / co-authored 56 book chapters, one monograph, and 158 research and review papers published in peer-reviewed journals.

• Volume 1: Integrating modern health technologies and traditional therapies to promote good healthSection 1: Role of biotechnological innovations in sustainable health1. An introduction to sustainable development, health, and innovative technologies2. Perspectives of traditional medicine in sustainable development3. The therapeutic influence of yoga on well-being and happiness4. Biotechnological innovations for sustainable health in the modern era: an overviewSection 2: Contemporary and emerging technologies in healthcare5. Contemporary technologies in healthcare systems: an overview6. Emerging aptamer diagnostics: next-generation point-of-care technology7. Biomedical innovations in telemedicine and human health8. Comparative analysis of CNN and transformer architectures for brain tumor diagnosis9. Nanomaterials: types, characterization methods, and antimicrobial mechanisms – a reviewSection 3: Artificial intelligence and healthcare10. Artificial intelligence in cancer diagnostics and personalized therapy11. AI in cardiology: applications, terminology, and limitations12. The role of AI in medicine with reference to covid-19: harmonizing ai advancements for sustainable healthcare13. Digital health solutions for pandemic management14. Advances in disease modeling systems: trends in cancer research and healthcare interventionsSection 4: Regenerative medicine and disease management15. Stem cells and their applications in regenerative medicine16. The role of stem cells in tissue engineering and futuristic medicine17. Molecular epidemiological approaches in disease management18. Impact of circadian rhythm on neurological disorders, cardiovascular diseases, and diabetes mellitusSection 5: Transformative technologies in reproductive health and aging19. Innovations in fertility preservation and cryopreservation techniques20. Challenges in menstrual hygiene management in urban slums: a mixed-method approach21. The role of computational biology in understanding uterine diseases22. Biotechnological advances in geriatric medicine23. The relationship between genetics, epigenetics, obesity, and type 2 diabetes24. Innovations in obesity and type 2 diabetes management25. Gut microbiome-microglia communications through the gut-brain axisVolume 2: Strategies for combating diseases through new therapeutics, drug development and nutritional approachesSection 1: Emerging technologies in drug development, delivery systems, and repurposing1. A historical overview of drug discovery and development2. Recent developments and trends in drug discovery3. Drug repurposing: exploring new applications for existing drugs4. A novel approach to anticancer research: non-mammalian models for drug developmentSection 2: Drug delivery and formulation5. Contemporary drug delivery systems: innovations and trends6. Crystal engineering as a platform for oral drug delivery7. Chewable gel as an emerging drug delivery technology for paediatric and geriatric populations8. From fields to pharmacies: the role of insects in medicine9. Phototherapeutics in breast cancer treatment10. Personalized drug delivery systems for chronic disease treatmentSection 3: Vaccine technologies11. Immunization strategies and innovations in vaccine development12. Innovations in the safety and efficacy assessment of new vaccines13. Emerging vaccine technologies: revolutionizing pandemic preventionSection 4: Nutrition, health, and natural products14. Clinical nutrition in health promotion and well-being15. The role of nutraceuticals in health promotion and disease prevention16. Natural products for sustainable health17. Traditional and novel fermented foods for the prevention of non-communicable diseases18. Secondary metabolites like flavonoids in cancer treatment: trends and future perspectives19. The preventive role of dietary polyphenols, probiotics, and physical activity in diabetes-induced complicationsSection 5: Herbal medicine and natural compounds20. Herbal interventions for the treatment of alcohol addiction21. Biological activities of rumex nepalensis and hedychium spicatum22. Biological activities of erigeron annuus and nerium indicum23. Vinegar production and its use in metabolic disorders: a role in human health